Cannabidiol‐rich non‐psychotropic Cannabis sativa L. oils attenuate peripheral neuropathy symptoms by regulation of CB2‐mediated microglial neuroinflammation
V Borgonetti, L Anceschi, V Brighenti… - Phytotherapy …, 2023 - Wiley Online Library
Neuropathic pain (NP) is a chronic disease that affects the normal quality of life of patients.
To date, the therapies available are only symptomatic and they are unable to reduce the …
To date, the therapies available are only symptomatic and they are unable to reduce the …
Cannabidiol-rich non-psychotropic Cannabis sativa L. oils attenuate peripheral neuropathy symptoms by regulation of CB2-mediated microglial neuroinflammation
V Borgonetti, L Anceschi, V Brighenti, L Corsi… - PHYTOTHERAPY …, 2023 - iris.unimore.it
Neuropathic pain (NP) is a chronic disease that affects the normal quality of life of patients.
To date, the therapies available are only symptomatic and they are unable to reduce the …
To date, the therapies available are only symptomatic and they are unable to reduce the …
Cannabidiol-rich non-psychotropic Cannabis sativa L. oils attenuate peripheral neuropathy symptoms by regulation of CB2-mediated microglial neuroinflammation
V Borgonetti, L Anceschi, V Brighenti… - Phytotherapy …, 2023 - pubmed.ncbi.nlm.nih.gov
Neuropathic pain (NP) is a chronic disease that affects the normal quality of life of patients.
To date, the therapies available are only symptomatic and they are unable to reduce the …
To date, the therapies available are only symptomatic and they are unable to reduce the …
Cannabidiol-rich non-psychotropic Cannabis sativa L. oils attenuate peripheral neuropathy symptoms by regulation of CB2-mediated microglial neuroinflammation
V Borgonetti, L Anceschi, V Brighenti… - PHYTOTHERAPY …, 2023 - usiena-air.unisi.it
Neuropathic pain (NP) is a chronic disease that affects the normal quality of life of patients.
To date, the therapies available are only symptomatic and they are unable to reduce the …
To date, the therapies available are only symptomatic and they are unable to reduce the …
Cannabidiol-rich non-psychotropic Cannabis sativa L. oils attenuate peripheral neuropathy symptoms by regulation of CB2-mediated microglial neuroinflammation.
V Borgonetti, L Anceschi, V Brighenti… - Phytotherapy …, 2022 - europepmc.org
Neuropathic pain (NP) is a chronic disease that affects the normal quality of life of patients.
To date, the therapies available are only symptomatic and they are unable to reduce the …
To date, the therapies available are only symptomatic and they are unable to reduce the …
Cannabidiol-rich non-psychotropic Cannabis sativa L. oils attenuate peripheral neuropathy symptoms by regulation of CB2-mediated microglial neuroinflammation.
V Borgonetti, L Anceschi, V Brighenti, L Corsi… - 2022 - cabidigitallibrary.org
Neuropathic pain (NP) is a chronic disease that affects the normal quality of life of patients.
To date, the therapies available are only symptomatic and they are unable to reduce the …
To date, the therapies available are only symptomatic and they are unable to reduce the …
Cannabidiol-rich non-psychotropic Cannabis sativa L. oils attenuate peripheral neuropathy symptoms by regulation of CB2-mediated microglial neuroinflammation
V Borgonetti, L Anceschi, V Brighenti, L Corsi… - PHYTOTHERAPY …, 2023 - flore.unifi.it
Neuropathic pain (NP) is a chronic disease that affects the normal quality of life of patients.
To date, the therapies available are only symptomatic and they are unable to reduce the …
To date, the therapies available are only symptomatic and they are unable to reduce the …